Epalrestat
Epalrestat CAS No .: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat é usado para prevenir, melhorar e tratar a neuropatia periférica (dormência, dor), parestesia vibracional e anormalidade cardíaca associada ao diabetes. ESPECIFICAÇÃO
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat é usado para prevenir, melhorar e tratar a neuropatia periférica (dormência, dor), parestesia vibracional e anormalidade cardíaca associada ao diabetes. ESPECIFICAÇÃO
P nome roduto | Epalrestat |
CAS | 82159-09-9 |
MF: | C15H13NO3S2 |
MW: | 319,4 |
Escreva aqui a sua mensagem e envie-a para nós